Loading…
Bronchodilator reversibility testing in COPD
[...]the reported bronchodilator responses are subject to the error that can result from regression to the mean. 2 The error can be minimised by relating the change to the mean level instead of the initial level, and it would be reassuring to see the data expressed in this form.
Saved in:
| Published in: | Thorax 2004-02, Vol.59 (2), p.178-9; author reply 179 |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | |
|---|---|
| cites | |
| container_end_page | 9; author reply 179 |
| container_issue | 2 |
| container_start_page | 178 |
| container_title | Thorax |
| container_volume | 59 |
| creator | Cotes, J E |
| description | [...]the reported bronchodilator responses are subject to the error that can result from regression to the mean. 2 The error can be minimised by relating the change to the mean level instead of the initial level, and it would be reassuring to see the data expressed in this form. |
| doi_str_mv | 10.1136/thorax.2003.014712 |
| format | article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1746924</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A114050723</galeid><sourcerecordid>A114050723</sourcerecordid><originalsourceid>FETCH-LOGICAL-b375t-c17f7b10334efa33e3d488d329a6ef7f7c0bd14a7301a174fedf910efa299d043</originalsourceid><addsrcrecordid>eNptkkFv1DAQhS0EokvhD3BAKyFxIstMxmsnF6SyUECq2goVDlwsJ5nsekns1slW7b_Hqy1dQJUPljzP38yznxAvEWaIpN6NqxDtzSwHoBmg1Jg_EhOUqsgoL9VjMQGQkCnS6kA8G4Y1ABSI-qk4SGIFqOYT8fZDDL5ehcZ1dgxxGvma4-Aq17nxdjryMDq_nDo_XZydf3wunrS2G_jF3X4ovh9_ulh8yU7OPn9dHJ1kFen5mNWoW10hEEluLRFTI4uiSUNZxW2q1VA1KK0mQItatty0JULS5mXZgKRD8X7HvdxUPTc1-zHazlxG19t4a4J15t-KdyuzDNcmwVSZbwFv7gAxXG2SCdO7oeaus57DZjAFIJWaVBK-_k-4Dpvok7nEKhKOoNzisp1qaTs2zrchda2X7Dk1D55bl46PECXMQeeU9LMH9Gk13Lv6wQuv_jZ87_TPP-0ncMPIN_d1G38ZpdOjm9MfC3NK5xfH3-RPU-z1Vb_e08Bsc2N2uTHb3Jhdbug36u2yYA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1781743094</pqid></control><display><type>article</type><title>Bronchodilator reversibility testing in COPD</title><source>Open Access: PubMed Central</source><creator>Cotes, J E</creator><creatorcontrib>Cotes, J E</creatorcontrib><description>[...]the reported bronchodilator responses are subject to the error that can result from regression to the mean. 2 The error can be minimised by relating the change to the mean level instead of the initial level, and it would be reassuring to see the data expressed in this form.</description><identifier>ISSN: 0040-6376</identifier><identifier>EISSN: 1468-3296</identifier><identifier>DOI: 10.1136/thorax.2003.014712</identifier><identifier>PMID: 14760165</identifier><identifier>CODEN: THORA7</identifier><language>eng</language><publisher>England: BMJ Publishing Group Ltd and British Thoracic Society</publisher><subject>bronchodilator ; Bronchodilator Agents ; chronic obstructive pulmonary disease ; Forced Expiratory Volume - drug effects ; Humans ; Letters to the Editor ; Pulmonary Disease, Chronic Obstructive - diagnosis ; Pulmonary Disease, Chronic Obstructive - physiopathology</subject><ispartof>Thorax, 2004-02, Vol.59 (2), p.178-9; author reply 179</ispartof><rights>Copyright 2004 Thorax</rights><rights>COPYRIGHT 2004 BMJ Publishing Group Ltd.</rights><rights>Copyright: 2004 Copyright 2004 Thorax</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1746924/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1746924/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14760165$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cotes, J E</creatorcontrib><title>Bronchodilator reversibility testing in COPD</title><title>Thorax</title><addtitle>Thorax</addtitle><description>[...]the reported bronchodilator responses are subject to the error that can result from regression to the mean. 2 The error can be minimised by relating the change to the mean level instead of the initial level, and it would be reassuring to see the data expressed in this form.</description><subject>bronchodilator</subject><subject>Bronchodilator Agents</subject><subject>chronic obstructive pulmonary disease</subject><subject>Forced Expiratory Volume - drug effects</subject><subject>Humans</subject><subject>Letters to the Editor</subject><subject>Pulmonary Disease, Chronic Obstructive - diagnosis</subject><subject>Pulmonary Disease, Chronic Obstructive - physiopathology</subject><issn>0040-6376</issn><issn>1468-3296</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNptkkFv1DAQhS0EokvhD3BAKyFxIstMxmsnF6SyUECq2goVDlwsJ5nsekns1slW7b_Hqy1dQJUPljzP38yznxAvEWaIpN6NqxDtzSwHoBmg1Jg_EhOUqsgoL9VjMQGQkCnS6kA8G4Y1ABSI-qk4SGIFqOYT8fZDDL5ehcZ1dgxxGvma4-Aq17nxdjryMDq_nDo_XZydf3wunrS2G_jF3X4ovh9_ulh8yU7OPn9dHJ1kFen5mNWoW10hEEluLRFTI4uiSUNZxW2q1VA1KK0mQItatty0JULS5mXZgKRD8X7HvdxUPTc1-zHazlxG19t4a4J15t-KdyuzDNcmwVSZbwFv7gAxXG2SCdO7oeaus57DZjAFIJWaVBK-_k-4Dpvok7nEKhKOoNzisp1qaTs2zrchda2X7Dk1D55bl46PECXMQeeU9LMH9Gk13Lv6wQuv_jZ87_TPP-0ncMPIN_d1G38ZpdOjm9MfC3NK5xfH3-RPU-z1Vb_e08Bsc2N2uTHb3Jhdbug36u2yYA</recordid><startdate>200402</startdate><enddate>200402</enddate><creator>Cotes, J E</creator><general>BMJ Publishing Group Ltd and British Thoracic Society</general><general>BMJ Publishing Group Ltd</general><general>BMJ Publishing Group LTD</general><general>BMJ Group</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>200402</creationdate><title>Bronchodilator reversibility testing in COPD</title><author>Cotes, J E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b375t-c17f7b10334efa33e3d488d329a6ef7f7c0bd14a7301a174fedf910efa299d043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>bronchodilator</topic><topic>Bronchodilator Agents</topic><topic>chronic obstructive pulmonary disease</topic><topic>Forced Expiratory Volume - drug effects</topic><topic>Humans</topic><topic>Letters to the Editor</topic><topic>Pulmonary Disease, Chronic Obstructive - diagnosis</topic><topic>Pulmonary Disease, Chronic Obstructive - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cotes, J E</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Thorax</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cotes, J E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bronchodilator reversibility testing in COPD</atitle><jtitle>Thorax</jtitle><addtitle>Thorax</addtitle><date>2004-02</date><risdate>2004</risdate><volume>59</volume><issue>2</issue><spage>178</spage><epage>9; author reply 179</epage><pages>178-9; author reply 179</pages><issn>0040-6376</issn><eissn>1468-3296</eissn><coden>THORA7</coden><abstract>[...]the reported bronchodilator responses are subject to the error that can result from regression to the mean. 2 The error can be minimised by relating the change to the mean level instead of the initial level, and it would be reassuring to see the data expressed in this form.</abstract><cop>England</cop><pub>BMJ Publishing Group Ltd and British Thoracic Society</pub><pmid>14760165</pmid><doi>10.1136/thorax.2003.014712</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0040-6376 |
| ispartof | Thorax, 2004-02, Vol.59 (2), p.178-9; author reply 179 |
| issn | 0040-6376 1468-3296 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1746924 |
| source | Open Access: PubMed Central |
| subjects | bronchodilator Bronchodilator Agents chronic obstructive pulmonary disease Forced Expiratory Volume - drug effects Humans Letters to the Editor Pulmonary Disease, Chronic Obstructive - diagnosis Pulmonary Disease, Chronic Obstructive - physiopathology |
| title | Bronchodilator reversibility testing in COPD |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T03%3A03%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bronchodilator%20reversibility%20testing%20in%20COPD&rft.jtitle=Thorax&rft.au=Cotes,%20J%20E&rft.date=2004-02&rft.volume=59&rft.issue=2&rft.spage=178&rft.epage=9;%20author%20reply%20179&rft.pages=178-9;%20author%20reply%20179&rft.issn=0040-6376&rft.eissn=1468-3296&rft.coden=THORA7&rft_id=info:doi/10.1136/thorax.2003.014712&rft_dat=%3Cgale_pubme%3EA114050723%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b375t-c17f7b10334efa33e3d488d329a6ef7f7c0bd14a7301a174fedf910efa299d043%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1781743094&rft_id=info:pmid/14760165&rft_galeid=A114050723&rfr_iscdi=true |